Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech for less than a buck. -- Ignore unavailable to you. Want to Upgrade?

To: Bald Man from Mars who wrote (483)	3/14/2000 5:12:00 PM
From: Mike McFarland	Respond to of 743

Well, maybe I am just thinking out loud and not communicating very well. The only important risk is that your biotech does not deliver therapies ...cures. And that is probably the best reason I can give for why this awful market is not shaking me out of my core positions. Genset is probably the one that takes the most guts to own--like the other genomics companies it is harder to see where the money is going to come from some day. But I sold on the way up, and am buying back on the way down, probably wont hurt myself too bad in that one even if it does keep trending down for awhile. Abbott will probably take them out someday anyway <g>. And I am sorta hoping that when we find out what they are mapping for CRXA it will really pop, hope it is something big like TB or HIV.